Leukemia
ASH 2022: Zanubrutinib in Patients With Relapsed or Refractory CLL/SLL
You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Advertisement
All Quizzes
Leukemia
ASH 2022: Efficacy of Triplet Combinations in Acute Myeloid Leukemia
Head & Neck/Thyroid Cancer
Genitourinary Cancers
Leukemia
Gastrointestinal Cancers
Safety and Efficacy of Sotorasib in KRAS-Mutated Pancreatic Cancer
Leukemia
ASH 2022: Impact of Momelotinib on Patient-Reported Quality of Life for Patients With Myelofibrosis
Lung Cancer
Breast Cancer
Multiple Myeloma
ASH 2022: Talquetamab for Relapsed or Refractory Multiple Myeloma
Lymphoma
Risk of ALCL Following Postmastectomy Implant Reconstruction
Breast Cancer
SABCS 2022: First-Line Ribociclib Plus Endocrine Therapy in Patients With Aggressive Breast Cancer
Lymphoma
ASH 2022: Re-evaluating the Standard of Care in Mantle Cell Lymphoma
Supportive Care
Gynecologic Cancers
Multiple Myeloma
Patients With Multiple Myeloma Receiving Salvage Treatment After BCMA-Directed CAR T-Cell Therapy
Supportive Care
Integrative Approaches to Managing Pain in Patients With Cancer: SIO/ASCO Guideline
Melanoma
Subset of Patients With a Very Low Risk of Dying From Melanoma
Lymphoma
NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas (Version 3.2022)
Oncology History
Leukemia
Real-World Cost of Pediatric ALL Care Among Commercially Insured Patients
Lymphoma
ASTRO 2022: A Novel Approach for Radiotherapy in Orbital Indolent B-Cell Lymphoma
Genitourinary Cancers
Head & Neck/Thyroid Cancer
ESMO 2022: Pembrolizumab and Chemoradiation for Locally Advanced Head and Neck Cancer
Gastrointestinal Cancers
Genitourinary Cancers
Radiopharmaceuticals for Treatment of Metastatic Castration-Resistant Prostate Cancer
Breast Cancer
Physician Survey: Breast Cancer Screening Among Transgender Patients
Lymphoma
Anaplastic Large-Cell Lymphoma of the Breast: Incidence in the United States
Genitourinary Cancers
ESMO 2022: COSMIC-313 Trial of Triplet Therapy in Advanced Renal Cell Carcinoma
Gynecologic Cancers
Lymphoma
Trends in Improvements in Survival Among Patients With DLBCL
Breast Cancer
Gastrointestinal Cancers
Consumption of Ultraprocessed Foods and Colorectal Cancer Risk
Lung Cancer
ESMO 2022: Air Pollution and Non–Small Cell Lung Cancer Risk
Melanoma
ESMO 2022: SWOG S1801 Trial of Timing of Pembrolizumab in Resected Advanced Melanoma
Genitourinary Cancers
Lymphoma
Trends in Cutaneous T-Cell Lymphoma Incidence in the United States
Oncology History
Multiple Myeloma
Lymphoma
Gastrointestinal Cancers
Head & Neck/Thyroid Cancer
Diet Quality and Survival Among Patients With Head and Neck Cancer
Melanoma
UV-Protective Behaviors Among American Indians and Alaskan Natives
Leukemia
Lung Cancer
Germline Testing for Patients With Lung Cancer: ASCO Plenary Series
Genitourinary Cancers
Older Patients With Advanced Bladder Cancer: Care Planning Priorities
Leukemia
Dosing of Tisagenlecleucel Among Pediatric Patients With Leukemia and Improved Outcomes
Head & Neck/Thyroid Cancer
Leukemia
Acute Leukemia Survival Outcomes Over Time in South Australia
Gynecologic Cancers
Lymphoma
Real-World Outcomes With Axicabtagene Ciloleucel Therapy for Large B-Cell Lymphoma
Breast Cancer
Lymphoma
Supportive Care
Multiple Myeloma: Caregiver Quality of Life and Psychological Distress
Leukemia
Phase III Trial Evaluates Quizartinib for FLT3-ITD–Positive AML
Gastrointestinal Cancers
Leukemia
Zanubrutinib for Untreated Patients With CLL/SLL: SEQUOIA Trial
Melanoma
Rapid Recommendation Update to ASCO Guideline for Systemic Treatment of Melanoma
Leukemia
Lung Cancer
Supportive Care
Trends in the Use of Medical Aid in Dying in the United States
Leukemia
ASCO 2022: Asciminib vs Bosutinib in Pretreated Patients With CML in Chronic Phase
Lymphoma
Characteristics of Advanced Extranodal Natural Killer/ T-Cell Lymphoma and its Treatment
Multiple Myeloma
Genitourinary Cancers
Lymphoma
Results From Large Real-World Cohorts on Treatment Outcomes in Patients With Mantle Cell Lymphoma
Leukemia
Gastrointestinal Cancers
Consumption of Sugar-Sweetened Beverages and Risk of Liver Cancer
Gynecologic Cancers
ASCO 2022: Real-World Data on Maintenance Olaparib in BRCA-Mutated Ovarian Cancer
Breast Cancer
Leukemia
ASCO 2022: Crenolanib Combined With Chemotherapy in Newly Diagnosed FLT3-Mutant AML
Gastrointestinal Cancers
ASCO 2022: Dostarlimab-gxly in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
Gastrointestinal Cancers
ASCO 2022: Nimotuzumab Plus Gemcitabine for KRAS Wild-Type Pancreatic Cancer
Leukemia
ASCO 2022: New Data on IDH2-Mutant Alleles and Endasidenib in AML
Melanoma
Head & Neck/Thyroid Cancer
The Financial Burden of Thyroid Cancer Care in the United States
Breast Cancer
ASCO 2022: Sacituzumab Govitecan-hziy for HR-Positive/HER2-Negative Advanced Breast Cancer
Leukemia
ASCO 2022: Measurable Residual Disease Testing as Prognostic Tool in Acute Myeloid Leukemia
Multiple Myeloma
ASCO 2022: Adding ASCT to Triplet/Maintenance Therapy for Newly Diagnosed Multiple Myeloma
Gastrointestinal Cancers
ASCO 2022: Panitumumab Plus mFOLFOX6 for Certain Patients With Metastatic Colorectal Cancer
Breast Cancer
ASCO 2022: T-DXd in HER2-Low Unresectable and/or Metastatic Breast Cancer
Gastrointestinal Cancers
ASCO 2022: Using ctDNA to Guide Adjuvant Chemotherapy in Colon Cancer
Lymphoma
ASCO 2022: Ibrutinib Added to Bendamustine/Rituximab for Older Patients With Mantle Cell Lymphoma
Supportive Care
ASCO 2022: State Public Welfare Spending and Disparities in Overall Survival
COVID-19
ASCO 2022: Disparities in Telemedicine Use for Patients With Cancer During the COVID-19 Pandemic
Breast Cancer
ASCO 2022: Black Patient Participation in Clinical Trials for Metastatic Breast Cancer
Multiple Myeloma
Lung Cancer
NCCN Guidelines for Non–Small Cell Lung Cancer (Version 3.2022)
Genitourinary Cancers
Lymphoma
CAR T-Cell Therapy: Rates of Rehospitalization and Emergency Department Visits Postinfusion
Leukemia
Addition of Ivosidenib to Azacitidine in Newly Diagnosed IDH1-Mutated AML
Supportive Care
Total Burden of Psychiatric Disorders Across All Common Adult Cancers
Lung Cancer
Gastrointestinal Cancers
Lymphoma
Innate Cell Engager AFM13 Plus Natural Killer Cells for Lymphoma
Gastrointestinal Cancers
MSI-H/dMMR Advanced Colorectal Cancer: Pembrolizumab vs Chemotherapy
Head & Neck/Thyroid Cancer
Tislelizumab Plus Chemotherapy for Recurrent/Metastatic Nasopharyngeal Cancer: RATIONALE-309
Lung Cancer
CheckMate 816: Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC
Supportive Care
NCCN Guidelines for the Management of Immunotherapy-Related Toxicities (Version 1.2022)
Gynecologic Cancers
Rucaparib vs Standard-of-Care Chemotherapy for BRCA1/2-Mutated, Relapsed Ovarian Cancer
COVID-19
Lymphoma
Immune Responses Among Patients With B-Cell Malignancies Post–COVID-19 Vaccination
Lymphoma
Multiple Myeloma
Combined BCMA and CD19 CAR T-Cells in Relapsed or Refractory Multiple Myeloma
Gastrointestinal Cancers
Breast Cancer
Oncology History
Gastrointestinal Cancers
Pembrolizumab/Trametinib vs Gemcitabine in Addition to SBRT for Pancreatic Cancer
Breast Cancer
Gastrointestinal Cancers
Immunotherapy Doublet in Patients With MSI-H/dMMR Metastatic Colorectal Cancer
Head & Neck/Thyroid Cancer
Strategy for De-Escalating Radiation Therapy for Patients With Oropharyngeal Cancer
Supportive Care
Genitourinary Cancers
Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer
Lymphoma
Supportive Care
Communication Skills Challenges for Advanced Practice Providers
Gastrointestinal Cancers
Lymphoma
Lung Cancer
Breast Cancer
Genitourinary Cancers
Breast Cancer
Outcomes of Patients With an Ultra-Low–Risk 70-Gene Signature in the MINDACT Trial
Lymphoma
Polatuzumab Vedotin-piiq Plus R-CHP vs R-CHOP in Previously Untreated DLBCL: POLARIX Trial
Gastrointestinal Cancers
Breast Cancer
Gastrointestinal Cancers
Combination Anti–PD-L1 and Anti–CTLA-4 Immunotherapy in Advanced Liver Cancer
Lung Cancer
Cancer During COVID-19: Resilience of Patients With Lung Cancer
Lymphoma
Using PET Scans to Direct Therapy Decisions in Advanced Hodgkin Lymphoma
Genitourinary Cancers
COVID-19
AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care
Oncology History
Lymphoma
Mosunetuzumab for Relapsed or Refractory Aggressive and Indolent B-Cell Non-Hodgkin Lymphomas
Gastrointestinal Cancers
Gastrointestinal Cancers
TOPAZ-1 Trial: Durvalumab and Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer
Gastrointestinal Cancers
Treatment Options for Patients With GIST Following Disease Progression
Supportive Care
Managing Breakthrough Cancer Pain: Role of Shared Decision-Making
Melanoma
Tebentafusp-tebn for the Treatment of Unresectable or Metastatic Uveal Melanoma
Genitourinary Cancers
Lung Cancer
T-DXd in Previously Treated Patients With Metastatic HER2-Mutant NSCLC
Breast Cancer
Case-Control Study of Risk of Cardiometabolic Risk Factors in Breast Cancer Survivors
Gastrointestinal Cancers
COVID-19
BNT162b2 COVID-19 Vaccination and Immune Response in Patients Undergoing Anticancer Treatment
Gynecologic Cancers
Dual Checkpoint Inhibition for Second-Line Treatment of Advanced Cervical Cancer
Lymphoma
Emerging Therapies and Current Unmet Needs for Patients With Relapsed or Refractory DLBCL
Head & Neck/Thyroid Cancer
Melanoma
Relatlimab and Nivolumab vs Nivolumab Alone in Untreated Advanced Melanoma
Genitourinary Cancers
Treatment-Related Regret Among Men With Localized Prostate Cancer: Examining Potential Factors
Lymphoma
Multiple Myeloma
Breast Cancer
COVID-19
COVID-19 Vaccination and SARS–CoV-2 Infection Among Patients With Cancer
Oncology History
Oncology History
Oncology History
Oncology History
Trending
CategoriesView All Quizzes
Tumor Type
- Breast Cancer
- Gastrointestinal Cancers
- Genitourinary Cancers
- Gynecologic Cancers
- Head & Neck/Thyroid Cancer
- Leukemia
- Lung Cancer
- Lymphoma
- Melanoma
- Multiple Myeloma
Conference Coverage
- 2021 ASH Annual Meeting & Exposition
- 2021 San Antonio Breast Cancer Symposium
- 2022 ASCO Annual Meeting
- 2022 ASCO Gastrointestinal Cancers Symposium
- 2022 ASCO Genitourinary Cancers Symposium
- 2022 ASCO Quality Care Symposium
- 2022 ASH Annual Meeting and Exposition
- 2022 Multidisciplinary Head and Neck Cancers Symposium
- 2022 San Antonio Breast Cancer Symposium
- AACR Annual Meeting 2022
- ASTRO Annual Meeting 2022
- ESMO Congress 2022